Changes in Erythropoiesis Stimulating Agent Use Under a Risk Evaluation and Mitigation Strategy (REMS) Program.

Ameet SarpatwariMengdong HeFrazer A TessemaJoshua J GagneAaron S Kesselheim

Published in: Drug safety (2020)

REMS program implementation and enforcement were not associated with significant changes in ESA initiation, adding to concerns over the degree to which certain REMS programs enhance patient safety.

Keyphrases

quality improvement
patient safety
climate change
public health
primary care
clinical evaluation